NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Metastatic Cancers

Countries: Spain

This is a national, multicenter, cross-sectional epidemiological study in adult Spanish participants diagnosed with advanced or metastatic melanoma.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Valid tumor samples from participants diagnosed with Stage IIIc or IV melanoma
* Written informed consent granted

Exclusion Criteria:

\- Do not fulfill one or more inclusion criteria

Locations (33)

Palma de Mallorca, Balearic Islands, Spain
Jerez de la Frontera, Cadiz, Spain
Santander, Cantabria, Spain
Castellon, Castellon, Spain
Donostia / San Sebastian, Guipuzcoa, Spain
A Coruña, LA Coruña, Spain
Cartagena (Murcia), Murcia, Spain
Pamplona, Navarre, Spain
Oviedo, Principality of Asturias, Spain
Santa Cruz de Tenerife, Tenerife, Spain
Bilbao, Vizcaya, Spain
Barcelona, Spain
Barcelona, Spain
Barcelona, Spain
Barcelona, Spain
Burgos, Spain
Cáceres, Spain
Girona, Spain
Granada, Spain
Lleida, Spain
Madrid, Spain
Madrid, Spain
Madrid, Spain
Madrid, Spain
Madrid, Spain
Málaga, Spain
Murcia, Spain
Salamanca, Spain
Seville, Spain
Toledo, Spain
+ 3 more on CT.gov